Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$11.81
+1.4%
$13.69
$11.37
$25.87
$2.24M-1.4111,193 shs1,469 shs
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$28.95
-0.3%
$28.06
$23.28
$29.80
$17.37M0.76,665 shs794 shs
JDOC
JPMorgan Healthcare Leaders ETF
$54.23
+0.2%
$51.57
$47.67
$60.43
$8.13M0.61332 shs683 shs
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$25.05
-7.2%
$19.48
$5.83
$29.73
$1.05BN/A209,116 shs360,016 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
-2.95%-1.73%-16.86%-26.45%-21.66%
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+0.35%-1.08%+4.19%+9.94%+0.43%
JDOC
JPMorgan Healthcare Leaders ETF
0.00%-1.04%+3.62%+7.22%-10.60%
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
+4.41%+4.21%+22.96%+104.78%+2,698,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$11.81
+1.4%
$13.69
$11.37
$25.87
$2.24M-1.4111,193 shs1,469 shs
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$28.95
-0.3%
$28.06
$23.28
$29.80
$17.37M0.76,665 shs794 shs
JDOC
JPMorgan Healthcare Leaders ETF
$54.23
+0.2%
$51.57
$47.67
$60.43
$8.13M0.61332 shs683 shs
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$25.05
-7.2%
$19.48
$5.83
$29.73
$1.05BN/A209,116 shs360,016 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
-2.95%-1.73%-16.86%-26.45%-21.66%
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+0.35%-1.08%+4.19%+9.94%+0.43%
JDOC
JPMorgan Healthcare Leaders ETF
0.00%-1.04%+3.62%+7.22%-10.60%
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
+4.41%+4.21%+22.96%+104.78%+2,698,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
0.00
N/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
2.51
Moderate Buy$28.95N/A
JDOC
JPMorgan Healthcare Leaders ETF
2.70
Moderate Buy$54.23N/A
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
2.50
Moderate Buy$38.3353.03% Upside

Current Analyst Ratings Breakdown

Latest ZBIO, BIS, JDOC, and FTXH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$35.00 ➝ $40.00
10/9/2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$30.00
10/8/2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/AN/AN/AN/AN/A
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$15M70.32N/AN/A$7.48 per share3.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/A14.51N/AN/AN/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/A22.43N/AN/AN/AN/AN/A
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
-$156.99M-$3.55N/AN/AN/A-59.21%-50.56%11/11/2025 (Estimated)

Latest ZBIO, BIS, JDOC, and FTXH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/11/2025Q3 2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
-$0.85N/AN/AN/A$10.00 millionN/A
8/12/2025Q2 2025
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
-$1.02-$1.25-$0.23-$1.25$5.00 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$0.605.08%N/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$0.461.59%N/AN/AN/A
JDOC
JPMorgan Healthcare Leaders ETF
$2.815.18%N/AN/AN/A
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$0.050.19%N/AN/A N/A

Latest ZBIO, BIS, JDOC, and FTXH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/23/2025
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
quarterly$0.15434.54%9/24/20259/24/20259/30/2025
9/24/2025
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
quarterly$0.14532.13%9/25/20259/25/20259/30/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A190,000N/AOptionable
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
147,000600,000N/AOptionable
JDOC
JPMorgan Healthcare Leaders ETF
N/A150,000N/AN/A
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
N/A42.11 million35.16 millionN/A

Recent News About These Companies

Enright buys Zenas Biopharma (ZBIO) stock worth $2.25 million
Q3 Earnings Estimate for Zenas BioPharma Issued By Wedbush
Zenas BioPharma (NASDAQ:ZBIO) Price Target Raised to $40.00
Zenas BioPharma's (ZBIO) "Buy" Rating Reiterated at HC Wainwright
Zenas BioPharma's (ZBIO) Sell (D-) Rating Reiterated at Weiss Ratings
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $6m

New MarketBeat Followers Over Time

Media Sentiment Over Time

ProShares UltraShort Nasdaq Biotechnology stock logo

ProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS

$11.81 +0.16 (+1.36%)
As of 03:16 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

First Trust Nasdaq Pharmaceuticals ETF stock logo

First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH

$28.95 -0.08 (-0.28%)
As of 03:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

JPMorgan Healthcare Leaders ETF NASDAQ:JDOC

$54.23 +0.11 (+0.20%)
As of 02:50 PM Eastern

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

Zenas BioPharma stock logo

Zenas BioPharma NASDAQ:ZBIO

$25.05 -1.94 (-7.19%)
As of 02:58 PM Eastern

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.